Risk of acute kidney injury in critically ill surgical patients with presumed pneumonia is not impacted by choice of methicillin-resistant staphylococcus aureus therapy

BACKGROUND: Vancomycin and linezolid are standard treatment options for nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. While acute kidney injury (AKI) is commonly attributed to vancomycin, existing data has not definitely confirmed vancomycin as an independent risk factor f...

Descripción completa

Detalles Bibliográficos
Autores principales: Billups, Kelsey B., Reed, Erica E., Phillips, Gary S., Stevenson, Kurt B., Steinberg, Steven M., Murphy, Claire V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869796/
https://www.ncbi.nlm.nih.gov/pubmed/29619336
http://dx.doi.org/10.4103/IJCIIS.IJCIIS_46_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869796/
https://www.ncbi.nlm.nih.gov/pubmed/29619336
http://dx.doi.org/10.4103/IJCIIS.IJCIIS_46_17

Ejemplares similares